Eyewire News: The Podcast
Eyewire News: The Podcast

11.18.26

J&J Acquisition Expands Retinal Disease Treatment Pipeline

Johnson & Johnson announces a major acquisition to expand its retinal diseases pipeline; CE Mark is granted for a retinal microcurrent stimulation device to treat dry AMD; and Newton’s Neurolens N3 eye-tracking measurement system is approved in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

Show More